2022 World Clinical Chemistry Analyzers and Reagent Market - Supplier Shares, Volume and Sales Segment Forecasts for 55 Tests in 98 Countries - Emerging Opportunities, Growth Strategies, Latest Technologies and Instrumentation Pipeline
This new 90-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test.
The report provides a granular strategic analysis of over 55 clinical chemistry assays performed in both centralized (hospitals, commercial laboratories), and POC/decentralized locations. The report explores future market trends; forecasts specimen, test and sales volume; estimates sales and market shares of key suppliers in major countries; compares features of leading analyzers; profiles key competitors; and identifies specific product and marketing opportunities for reagent and instrument suppliers.
To fit your research budget and receive sections of this report or specific data on geographic regions, countries, markets, companies, technologies and products, select the exact information you need from our In Vitro Diagnostics Database.
Rationale
The clinical chemistry market is undergoing significant transformation, caused by convergence of new and more stringent regulations; advances in diagnostic technologies, system engineering, automation, and IT; and intensifying competition. Some segments, like routine chemistry, are already resembling commodity markets, where product positioning and cost per test are more critical than underlying technology. This evolving marketplace creates exciting opportunities for a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, and calibrators.
Geographic Regions and Countries
Asia-Pacific
Australia, Bangladesh, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Pakistan, Philippines, Singapore, South Korea, Taiwan, Thailand, Turkey, Vietnam
Europe
Albania, Austria, Belarus, Belgium, Bulgaria, Croatia, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Georgia, Germany, Greece, Hungary, Iceland, Ireland, Italy, Kazakhstan, Latvia, Lithuania, Malta, Moldova, Netherlands, Norway, Poland, Portugal, Romania, Russia, Serbia, Slovakia, Slovenia, Spain, Sweden, Switzerland, UK, Ukraine
Latin America
Argentina, Bolivia, Brazil, Chile, Colombia, Costa Rica, Cuba, Dominican Republic, Ecuador, El Salvador, Guatemala, Haiti, Honduras, Jamaica, Mexico, Nicaragua, Panama, Paraguay, Peru, Puerto Rico, Uruguay, Venezuela
Middle East
Bahrain, Iran, Iraq, Israel, Jordan, Kuwait, Lebanon, Oman, Qatar, Saudi Arabia, United Arab Emirates
North America
Canada, Mexico, USA
Market Segmentation Analysis
- Comprehensive review of the market dynamics, trends, structure, size, growth, and key suppliers.
- Test volume and sales forecasts for over 55 clinical chemistry assays.
Individual Tests Analyzed in the Report
Albumin, Alkaline Phosphatase, ALT/SGPT, Ammonia, Amylase, Apolipoprotein A-1, Apolipoprotein B, AST/SGOT, Beta-Hydroxybutyrate, Bilirubin (Direct), Bilirubin (Total), BNP, BUN (Blood Urea Nitrogen), Calcitonin, Calcium, Carbon Dioxide/Bicarbonate, Cardio hs CRP, Chloride, Cholesterol, Cholinesterase, Creatine Kinase (CK), CK-MB, Creatinine, CRP, Cystatin C, Ferritin, Fructosamine, GGT, Glucose, HDL Cholesterol, Homocysteine, hs-CRP, Insulin, Iron, Iron (Total Binding Capacity), Iron (Unsaturated Binding Capacity), LDH, LDL Cholesterol, LDL Cholesterol Direct, Lipase, Lipoprotein a, Magnesium, Microalbumin, Myoglobin, NT-proBNP, Phosphorus, Potassium, Sodium, ST2, Total Protein, Transferrin, Triglycerides, Troponin, Uric Acid
Current and Emerging Products
- Analysis of current and emerging clinical chemistry tests.
- Review of current instrumentation technologies, and feature comparison of high-, medium-, and low-volume/POC analyzers.
Technology Review
- Assessment of current and emerging technologies, and their potential market applications.
- Companies developing or marketing new technologies and products by test.
Strategic Recommendations
- New product development opportunities with significant market appeal.
Alternative market penetration strategies.
Potential market entry barriers and risks.
Competitive Assessments
- Strategic assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, collaborative arrangements and new products in R&D. The companies analyzed in the report include:
Abbott Laboratories
Agilent Technologies
Beckman Coulter/Danaher
bioMerieux
Bio-Rad
DiaSorin
Eiken Chemical
Fujifilm Wako
Fujirebio
Grifols
Instrumentation Laboratory/Werfen
Kyowa Medex
Ortho-Clinical Diagnostics
PerkinElmer
Quest Diagnostics
Roche
Siemens Healthineers
Sysmex
Thermo Fisher
Tosoh
Please note: The delivery time for the electronic version of this report is between 1-3 business days to allow the preparation of an updated version prior to dispatch.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook